Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors
- 8 October 2004
- Vol. 101 (10) , 2341-2350
- https://doi.org/10.1002/cncr.20634
Abstract
BACKGROUND Neuropilins (NRPs) are characterized as coreceptors of vascular endothelial growth factor (VEGF). In the current study, the authors assessed the expression of NRPs, VEGF, and vascular endothelial growth factor receptors (VEGFRs), as well as VEGF‐induced cell proliferation, in pancreatic carcinoma cell lines and tissue specimens. METHODS Human pancreatic carcinoma cell lines (Panc‐1 and MIA PaCa‐2), normal human pancreatic ductal epithelial cells (HPDE), and human umbilical vein endothelial cells (HUVECs) were cultured. Human pancreatic adenocarcinoma tissue specimens were also studied. Expression levels of NRPs, VEGFRs, and VEGF were determined by real‐time polymerase chain reaction analysis and immunostaining. Cell proliferation was examined using a [3H]thymidine incorporation assay. RESULTS Both NRP‐1 and NRP‐2 were expressed in Panc‐1 cells, HPDE cells, and HUVECs but were expressed minimally in MIA PaCa‐2 cells. Panc‐1 expressed 30 times more NRP‐1 mRNA than NRP‐2 mRNA. NRP‐1 levels in Panc‐1 cells were 5.3 times higher than in HPDE cells but were similar to NRP‐1 levels in HUVECs. NRP‐2 levels in Panc‐1 cells were similar to NRP‐2 levels in HPDE cells but lower than NRP‐2 levels in HUVECs. Expression of all three VEGFRs was observed only in HUVECs. However, VEGF mRNA was detected in all cell types except for HUVECs. NRP‐1 immunoreactivity levels were much higher than NRP‐2 immunoreactivity levels in Panc‐1 and human pancreatic adenocarcinoma tissue specimens, whereas VEGFRs were not detected in either of these two settings. In response to VEGF165, [3H]thymidine incorporation in Panc‐1 cells increased significantly (by 61%; P < 0.01). A monoclonal antibody against human NRP‐1 significantly blocked VEGF‐induced cell proliferation in Panc‐1 cells. CONCLUSIONS The pancreatic carcinoma cell line Panc‐1 and adenocarcinoma tissue specimens expressed high levels of NRP‐1 and VEGF, but not VEGFRs, and exogenous VEGF significantly increased NRP‐1‐mediated, but not VEGFR‐mediated, Panc‐1 cell proliferation. These data suggested that NRP‐1 may be involved in the pathogenesis of pancreatic carcinoma. Cancer 2004. © 2004 American Cancer Society.Keywords
This publication has 36 references indexed in Scilit:
- Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin‐1 by epidermal growth factor in human pancreatic carcinomaCancer, 2003
- Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell linesThe Journal of Pathology, 2003
- Neuropilin 1 and neuropilin 2 co‐expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinomaCancer, 2002
- Neuropilin‐1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: A possible marker for the progression of breast cancerInternational Journal of Cancer, 2002
- Neuropilin‐2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumoursThe Journal of Pathology, 2002
- Lymphatic endothelium: a new frontier of metastasis researchNature Cell Biology, 2002
- VEGFR‐3 in adult angiogenesisThe Journal of Pathology, 2001
- Vascular Endothelial Growth Factor: Acting as an Autocrine Growth Factor for Human Gastric Adenocarcinoma Cell MGC803Biochemical and Biophysical Research Communications, 2001
- Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancerInternational Journal of Cancer, 1999
- VEGFs, receptors and angiogenesisSeminars in Cancer Biology, 1999